The acquisition allows JAT to take control of the supply chain of one of its major growing products. As a result, JAT will eliminate reliance on contract manufacturers for its milk powder products, it will increase its profits by capturing the manufacturer’s margin and business risk will be reduced.
Sounds good to me also like the part about selling Lactoferrin products to other producers, should add a few bucks to the kitty. Not having to wait their turn from 3rd parties is a big bonus.
- Forums
- ASX - By Stock
- Ann: Acquisition of 70% of Australian Infant Formula Manufacturer
The acquisition allows JAT to take control of the supply chain...
-
- There are more pages in this discussion • 914 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
41.5¢ |
Change
-0.035(7.78%) |
Mkt cap ! $34.55M |
Open | High | Low | Value | Volume |
42.0¢ | 43.5¢ | 40.5¢ | $67.71K | 163.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21353 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21353 | 0.415 |
1 | 3690 | 0.410 |
4 | 8819 | 0.405 |
5 | 40000 | 0.400 |
6 | 27348 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 1000 | 1 |
0.450 | 23300 | 1 |
0.490 | 17234 | 1 |
0.540 | 33334 | 1 |
0.550 | 11677 | 1 |
Last trade - 15.45pm 13/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online